Literature DB >> 17404834

Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures.

Julie A Gaasch1, Werner J Geldenhuys, Paul R Lockman, David D Allen, Cornelis J Van der Schyf.   

Abstract

Recent studies suggest that iron enters cardiomyocytes via the L-type voltage-gated calcium channel (VGCC). The neuronal VGCC may also provide iron entry. As with calcium, extraneous iron is associated with the pathology and progression of neurodegenerative diseases such as Parkinson's and Alzheimer's disease. VGCCs, ubiquitously expressed, may be an important route of excessive entry for both iron and calcium, contributing to cell toxicity or death. We evaluated the uptake of (45)Ca(2+) and (55)Fe(2+) into NGF-treated rat PC12, and murine N-2alpha cells. Iron not only competed with calcium for entry into these cells, but iron uptake (similar to calcium uptake) was inhibited by nimodipine, a specific L-type VGCC blocker, and enhanced by FPL 64176, an L-VGCC activator, in a dose-dependent manner. Taken together, these data suggest that voltage-gated calcium channels are an alternate route for iron entry into neuronal cells under conditions that promote cellular iron overload toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404834     DOI: 10.1007/s11064-007-9313-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  48 in total

Review 1.  Iron metabolism.

Authors:  P Aisen; M Wessling-Resnick; E A Leibold
Journal:  Curr Opin Chem Biol       Date:  1999-04       Impact factor: 8.822

2.  Functional interactions between two Ca2+ channel activators, (S)-Bay K 8644 and FPL 64176, in smooth muscle.

Authors:  D Rampe; R C Dage
Journal:  Mol Pharmacol       Date:  1992-04       Impact factor: 4.436

3.  FPL 64176 modification of Ca(V)1.2 L-type calcium channels: dissociation of effects on ionic current and gating current.

Authors:  Stefan I McDonough; Yasuo Mori; Bruce P Bean
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

Review 4.  Iron absorption and cellular transport: the mobilferrin/paraferritin paradigm.

Authors:  J N Umbreit; M E Conrad; E G Moore; L F Latour
Journal:  Semin Hematol       Date:  1998-01       Impact factor: 3.851

Review 5.  Iron: a pathological mediator of Alzheimer disease?

Authors:  Glenda M Bishop; Stephen R Robinson; Quan Liu; George Perry; Craig S Atwood; Mark A Smith
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

6.  Treatment of PC12 cells with nerve growth factor increases iron uptake.

Authors:  J Mwanjewe; B K Hui; M D Coughlin; A K Grover
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

7.  Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload.

Authors:  R G Tsushima; A D Wickenden; R A Bouchard; G Y Oudit; P P Liu; P H Backx
Journal:  Circ Res       Date:  1999-06-11       Impact factor: 17.367

Review 8.  Pharmacology of nimodipine. A review.

Authors:  A Scriabine; W van den Kerckhoff
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

9.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Authors:  E Sofic; P Riederer; H Heinsen; H Beckmann; G P Reynolds; G Hebenstreit; M B Youdim
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  Amlodipine decreases iron uptake and oxygen free radical production in the heart of chronically iron overloaded mice.

Authors:  Sarah Crowe; Wally J Bartfay
Journal:  Biol Res Nurs       Date:  2002-04       Impact factor: 2.522

View more
  19 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

2.  Development and validation of an LC-MS/MS method for determination of the L-type voltage-gated calcium channel/NMDA receptor antagonist NGP1-01 in mouse serum.

Authors:  Harini Jogiraju; Xiang Zhou; Ashta Lakshmi Prasad Gobburi; Kiran K Pedada; Werner J Geldenhuys; Cornelis J Van der Schyf; Samuel D Crish; David J Anderson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-06-02       Impact factor: 3.205

3.  Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types.

Authors:  J A Lockman; W J Geldenhuys; K A Bohn; S F Desilva; D D Allen; C J Van der Schyf
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

4.  L-type Calcium Channels are Involved in Iron-induced Neurotoxicity in Primary Cultured Ventral Mesencephalon Neurons of Rats.

Authors:  Yu-Yu Xu; Wen-Ping Wan; Sha Zhao; Ze-Gang Ma
Journal:  Neurosci Bull       Date:  2019-09-03       Impact factor: 5.203

5.  Synergistic accumulation of iron and zinc by cultured astrocytes.

Authors:  Glenda M Bishop; Ivo F Scheiber; Ralf Dringen; Stephen R Robinson
Journal:  J Neural Transm (Vienna)       Date:  2010-06-12       Impact factor: 3.575

6.  Fe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influx.

Authors:  Kyle V Lopin; I Patrick Gray; Carlos A Obejero-Paz; Frank Thévenod; Stephen W Jones
Journal:  Mol Pharmacol       Date:  2012-09-12       Impact factor: 4.436

7.  L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats.

Authors:  Rong Wang; Zegang Ma; Jun Wang; Junxia Xie
Journal:  Neurotox Res       Date:  2011-09-07       Impact factor: 3.911

8.  Nifedipine prevents iron accumulation and reverses iron-overload-induced dopamine neuron degeneration in the substantia nigra of rats.

Authors:  ZeGang Ma; Yu Zhou; JunXia Xie
Journal:  Neurotox Res       Date:  2012-01-19       Impact factor: 3.911

Review 9.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

10.  Is the iron donor lipocalin 2 implicated in the pathophysiology of hereditary hemochromatosis?

Authors:  Hua Huang; Shizuo Akira; Manuela M Santos
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.